advertisement
11.3.4 Betablocker (14)
Showing records 1 to 14
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker9894 Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers
Mungan NK; Wilson TW; Nischal KK; Koren G; Levin AV
Journal of AAPOS 2003; 7: 69-70
9897 Efficacy and safety of substituting a twice-daily regimen of timolol with a single daily instillation of nonpreserved beta-blocker in patients with chronic glaucoma or ocular hypertension
Bron A; Chiambaretta F; Pouliquen P; Rigal D; Rouland JF
Journal Français d'Ophtalmologie 2003; 26: 668-674
9907 Hypotony and choroidal effusion induced by topical timolol and dorzolamide in patients with previous glaucoma drainage device implantation
Callahan C; Ayyala RS
Ophthalmic Surgery Lasers and Imaging 2003; 34: 467-469
9899 Rate of response to latanoprost or timolol in patients with ocular hypertension or glaucoma
Camras CB; Hedman K; US Latanoprost Study Group
Journal of Glaucoma 2003; 12: 466-469
9906 A six-week, parallel, randomized, double-blind study comparing the efficacy and safety of the 0.5% timolol/2.0% MK-507 combination b.i.d. to the concomitant administration of 0.5% timolol b.i.d. and 2.0% MK-507 b.i.d.
Chen YF; Yang CH; Hung PT
Journal of Ocular Pharmacology and Therapeutics 2003; 19: 417-423
9900 A three-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension
Coleman AL; Lerner F; Bernstein P; Whitcup SM; Lumigan/Cosopt Study Group
Ophthalmology 2003; 110: 2362-2368
9904 Assessing the cost-effectiveness of switching from a β-blocker to latanoprost in the treatment of ocular hypertension
Costagliola C; Parmeggiani F; Sebastiani A
Expert Opinion in Pharmacotherapy 2003; 4: 1775-1788
9898 Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride
Ishibashi T; Yokoi N; Kinoshita S
Journal of Glaucoma 2003; 12: 486-490
9896 Metipranolol attenuates lipid peroxidation in rat brain: a comparative study with other antiglaucoma drugs
Melena J; Osborne NN
Graefe's Archive for Clinical and Experimental Ophthalmology 2003; 241: 827-833
9903 Estimating the long-term visual field consequences of average daily intraocular pressure and variance: A clinical trial comparing timolol, latanoprost and travoprost
Nordmann JP; LePen C; Lilliu H; Berdeaux G
Clinical Drug Investigation 2003; 23: 431-438
9908 Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices
Pajic B
Current Medical Research and Opinion 2003; 19: 95-101
9905 Ocular hypotensive effect of nipradilol ophthalmic solution for normal-tension glaucoma
Yukawa E; Taketani F; Matsuura T; Nitta N; Ishibashi H; Morishita K; Hara Y
Japanese Journal of Clinical Ophthalmology 2003; 57: 1471-1475
9885 Evaluation of retinal haemodynamics and retinal function after application of dorzolamide, timolol and latanoprost in newly diagnosed open-angle glaucoma patients
Arend O; Harris A; Wolter P; Remky A
Acta Ophthalmologica Scandinavica 2003; 81: 474-479
9948 A combination of timoptol and L-arginine HCl: a regulator of intraocular pressure in rabbits
Veselovsky J; Olah Z; Vesela A; Gressnerova S
Česka a Slovenska Oftalmologie 2003; 59: 295-302
